EGRX

Eagle Pharmaceuticals, Inc.

Delisted

EGRX was delisted on the 2nd of October, 2024.

175 hedge funds and large institutions have $1.21B invested in Eagle Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 76 increasing their positions, 42 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
175
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$12.4M
Puts
$4.72M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$144M
2
$94.6M
3
$76.4M
4
$75M
5
$65.4M
6
$54.9M
7
$54.8M
8
$51.4M
9
$44.3M
10
$41.5M
11
$35.4M
12
$32.1M
13
$26M
14
$22.9M
15
$22M
16
$15.9M
17
$15.8M
18
$13.8M
19
$12.4M
20
$11.7M
21
$10.8M
22
$10.5M
23
$10.4M
24
$10.4M
25
$9.19M